Earnings preview: S&N facing another tough quarter
This article was originally published in Clinica
Executive Summary
Smith & Nephew is due to reports its first-quarter results on 2 May, with analysts predicting sales of $1.08 billion (flat against last year’s Q1), and adjusted earnings of 18.4¢ per share, down from 19.5¢ in Q1 2012. The company’s orthopedic reconstructive products look set to underperform again, but analysts are expecting a more positive showing from its wound care business.